Immune Disorders

Analysis of all known genes associated with immune disorders

Molecular genetic testing is integral to diagnosing primary immunodeficiencies (PID) and autoinflammatory/autoimmune diseases (AID). While blood and urine tests are an important diagnostic precursor to establishing a tentative diagnosis, often only the detection of a pathogenic genetic alteration can definitively confirm a suspicion and establish a definitive diagnosis. The result of genetic testing can thus be decisive for further clinical patient management concerning vaccinations, medication, and transplantation.

The Diagnostic Panel for Immune Disorders covers all known monogenic diseases of the autoinflammatory and autoimmune spectrum (gene sets AID) and includes all currently known genes for primary immunodeficiencies (gene sets PID). The Panel is based on our proprietary, high-quality ExomeXtra® enrichment, covering all protein-coding regions as well as intronic and intergenic variants described as disease-relevant in the databases HGMD and ClinVar. In addition, the ExomeXtra® enrichment enables a genome-wide CNV calling with similar performance to array CGH. It thus provides the ideal basis for genetic diagnostics.

Are you insured in Germany? Our colleagues at the Zentrum für Humangenetik Tübingen will gladly support you!

What We Offer with the Panel for Immune Disorders

Updates

The gene selection is regularly adapted to the current scientific knowledge

Flexibility

With ExomeXtra®, gene sets addressing different diseases can be combined

Comprehensive Medical Report

Including the ACMG criteria used to classify the variants

Highest Quality

All steps are carried out in-house

Our Promise to You

Graues Icon das die Dauer symbolisiert

Fast Turnaround Time

2–4 weeks after sample receipt

Icon zur Visualisierung unseres Sicherheitsversprechens

Safety

Highest confidentiality and quality standards

Icon das Zuverlässigkeit symbolisiert

Reliability

Reliable support throughout all steps

Einfache grafische Darstellung eines Befund

Comprehensibility

Clearly prepared medical report

Your Benefits

It is possible to request single or multiple predefined gene sets. In addition to the complete analysis of the genes of the requested gene set, we extend the analysis by additional genes for differential diagnosis. We report variants of unknown significance (ACMG class 3) and pathogenic and probably pathogenic variants (ACMG classes 4 and 5) for the primarily ordered gene set. For the genes included due to differential diagnosis, we restrict the reporting to pathogenic and probably pathogenic variants (ACMG classes 4 and 5), which could be related to the indication of the person seeking advice.

The Diagnostic Panel for Immune Disorders is based on CeGaT’s ExomeXtra® enrichment. This allows, without additional sequencing, phenotypically eligible gene sets of other CeGaT panels or single genes to be additionally ordered. If you would like to assemble an individual panel, please feel free to contact us. We will be happy to support you.

In addition to the primary diagnostic assignment, the assessment of ACMG genes and pharmacogenetic profiling may also be ordered.

Method

The enrichment of the coding regions and the adjacent intronic regions is performed using an in-solution hybridization technology. The selection of the targeted regions and the design of the enrichment baits is performed in-house. High-throughput sequencing is performed on our Illumina platforms. Bioinformatic processing of the data is achieved using an in-house computer cluster.

Following data processing, our team of scientists and specialists in human genetics analyze the data and issue a medical report.

Sample Report

General Information

Material

  • 1-2 ml EDTA blood (recommended sample type) or
  • 1-2 µg genomic DNA
  • Order Form with declaration of consent

Here you can find more information on how to ship your sample safely.

Costs

The prices for our human genetic diagnostics depend on the size of the selected diagnostic panel and the selected gene sets. All prices include sequencing, bioinformatic analysis, and issuing of a medical report by our team of experts in human genetic diagnostics.

Diagnostic Process

Icon process flow

Counseling & Test Selection

Icon zur Darstellung eines Prozessablaufs
Icon process flow

Sampling & Shipment

Icon zur Darstellung eines Prozessablaufs
Icon process flow

Sample Analysis

Icon zur Darstellung eines Prozessablaufs
Icon process flow

Medical Report & Counseling

Gene Sets – Immune Disorders

Primary Antibody Deficiencies (40 Genes, PID01)

Incl. hyper IgM syndrome, CVID, agammaglobulinemia, activated PI3Kdelta syndromes

AICDA, ARHGEF1, ATM, ATP6AP1, BLNK, BTK, CARD11, CD19, CD40, CD40LG, CD79A, CD79B, CD81, CR2, CTNNBL1, FNIP1, ICOS, IGLL1, IKZF1, IRF2BP2, MOGS, MS4A1, NFKB1, NFKB2, PIK3CD, PIK3CG, PIK3R1, PLCG2, PTEN, RAC2, SEC61A1, SH3KBP1, SLC39A7, SPI1, TCF3, TNFRSF13B, TNFRSF13C, TOP2B, TRNT1, UNG

Severe Combined Immunodeficiencies (SCID) (20 Genes, PID02)

incl. Inflammation of the skin, joints and bones, vasculitis

ADA, AK2, BCL11B, CD3D, CD3E, CORO1A, DCLRE1C, IL2RG, IL7R, JAK3, LAT, LIG4, NHEJ1, PRKDC, PTPRC, RAC2, RAG1, RAG2, RPSA, TBX1

Combined Immunodeficiencies (CID) (51 Genes, PID03)

ARPC1B, ARPC5, ATM, B2M, BCL10, CARD11, CD27, CD3E, CD3G, CD40, CD40LG, CD8A, CIITA, DOCK2, DOCK8, FCHO1, GINS1, ICOS, IKBKB, IKZF1, IKZF2, IL21, IL21R, ITK, LCK, LIG1, MALT1, MAP3K14, MCM10, MCM4, MSN, MTHFD1, ORAI1, PNP, REL, RELA, RELB, RFX5, RFXANK, RFXAP, SASH3, SLC46A1, SP110, STIM1, STK4, TAP1, TAP2, TAPBP, TFRC, TNFRSF4, ZAP70

Hyper-IgE Syndrome (15 Genes, PID04)

ARPC1B, CARD11, DOCK8, ERBIN, IL6R, IL6ST, PGM3, SPINK5, STAT3, STAT6, TGFBR1, TGFBR2, WAS, WIPF1, ZNF341

Defects of the Complement System (17 Genes, PID06)

C1QA, C1QB, C1QC, C1R, C1S, C2, C3, C5, C6, C7, C8A, C8B, CFD, CFH, CFI, CFP, FCN3

Congenital Neutropenia (23 Genes, PID07)

CEBPE, CLPB, CSF3R, CXCR2, CXCR4, DNAJC21, EFL1, ELANE, G6PC3, GFI1, GINS1, HAX1, JAGN1, LAMTOR2, SBDS, SLC37A4, SMARCD2, SRP54, TAFAZZIN, USB1, VPS13B, VPS45, WAS

Chronic Granulomatous Disease (Defects of Respiratory Burst) (7 Genes, PID08)

CYBA, CYBB, CYBC1, G6PD, NCF1 (c.75_76delGT), NCF2, NCF4

Chronic Mucocutaneous Candidiasis (8 Genes, PID10)

AIRE, CARD9, IL17F, IL17RA, IL17RC, RORC, STAT1, TRAF3IP2

Susceptibility to Mycobacterial Infections (17 Genes, PID11)

CYBB, IFNG, IFNGR1, IFNGR2, IL12B, IL12RB1, IL23R, IRF1, IRF8, ISG15, JAK1, MCTS1, RORC, SPPL2A, STAT1, TBX21, TYK2

Susceptibility to Viral Infections (15 Genes, PID12)

FCGR3A, GATA2, GINS1, IFIH1, IFNAR1, IFNAR2, IRF7, IRF9, MCM4, POLR3A, POLR3F, STAT1, STAT2, TLR3, ZNFX1

Periodic Fever Syndromes with/without Urticaria (9 Genes, AID01)

ELANE, MEFV, MVK, NLRP12, NLRP3, NOD2, OTULIN, PSTPIP1, TNFRSF1A

Further Autoinflammatory Disorders without Type I
Interferonopathies (35 Genes, AID02)

Incl. inflammation of the skin, joints and bones, vasculitis

ADA2, ADAM17, AP1S3, ARPC1B, CARD11, CARD14, COPA, DPP9, ELF4, HAVCR2, HCK, IL1RN, IL36RN, LPIN2, LYN, NCKAP1L, NFKB1, NLRC4, NLRP1, NOD2, OTULIN, PLCG2, POMP, PSMA3, PSMB10, PSMB4, PSMB8, PSMB9, PSMG2, PSTPIP1, RELA, RIPK1, SLC29A3, SYK, TNFAIP3

Type I Interferonopathies (25 Genes, AID07)

Incl. interferonopathies with leading neurological symptoms, Aicardi-Goutièressyndrome and systemic lupus erythematosus  (SLE) / chilblain lupus

ADA2, ADAR, C1QA, C1QB, C1QC, C2, C2orf69, C3, DNASE1L3, DNASE2, IFIH1, LSM11, OAS1, POLA1, PRKCD, RNASEH2A, RNASEH2B, RNASEH2C, RNU7-1, SAMHD1, STAT2, STING1, TLR7, TREX1, UNC93B1

Immune Dysregulation with Early Onset Colitis (IBD) (34 Genes, AID03)

AICDA, ARPC1B, BACH2, CD3G, CD40LG, CD55, CTLA4, CYBA, CYBB, CYBC1, ELF4, FOXP3, GUCY2C, IL10, IL10RA, IL10RB, LRBA, MALT1, NCF1, NCF2, NCF4, NLRC4, PIK3CD, RIPK1, SKIC2, SKIC3, SLC37A4, SLCO2A1, STAT3, TGFB1, TNFAIP3, TRIM22, TTC7A, XIAP

Primary Hemophagocytic Lymphohistiocytosis (HLH) (11 Genes, AID04)

AP3B1, AP3D1, HAVCR2, LIPA, LYST, PRF1, RAB27A, SLC7A7, STX11, STXBP2, UNC13D

Abnormal Lymphoproliferation (29 Genes, AID05)

EBV susceptibility with lymphoproliferation / ALPS

CARMIL2, CASP10, CASP8, CD27, CD70, CORO1A, CTPS1, FADD, FAS, FASLG, IL2RA, IL2RB, ITK, KRAS, LAT, LRBA, MAGT1, NFKB1, NRAS, PIK3CD, PIK3R1, PRKCD, RASGRP1, SH2D1A, STAT3, STK4, TET2, TNFRSF9, XIAP

Regulatory T-Cells Defects / IPEX (16 Genes, AID06)

BACH2, CARMIL2, CTLA4, DEF6, DOCK8, FAS, FASLG, FOXP3, IKBKB, IKZF1, IL2RA, IL2RB, LRBA, MALT1, STAT3, STAT5B

Gene Directory – Panel for Immune Disorders

ADA, ADA2, ADAM17, ADAR, AICDA, AIRE, AK2, AP1S3, AP3B1, AP3D1, ARHGEF1, ARPC1B, ARPC5, ATM, ATP6AP1, B2M, BACH2, BCL10, BCL11B, BLNK, BTK, C1QA, C1QB, C1QC, C1R, C1S, C2, C2orf69, C3, C5, C6, C7, C8A, C8B, CARD11, CARD14, CARD9, CARMIL2, CASP10, CASP8, CD19, CD27, CD3D, CD3E, CD3G, CD40, CD40LG, CD55, CD70, CD79A, CD79B, CD81, CD8A, CEBPE, CFD, CFH, CFI, CFP, CIITA, CLPB, COPA, CORO1A, CR2, CSF3R, CTLA4, CTNNBL1, CTPS1, CXCR2, CXCR4, CYBA, CYBB, CYBC1, DCLRE1C, DEF6, DNAJC21, DNASE1L3, DNASE2, DOCK2, DOCK8, DPP9, EFL1, ELANE, ELF4, ERBIN, FADD, FAS, FASLG, FCHO1, FCN3, FNIP1, FOXP3, G6PC3, G6PD, GATA2, GFI1, GINS1, GUCY2C, HAVCR2, HAX1, HCK, ICOS, IFIH1, IFNAR1, IFNAR2, IFNG, IFNGR1, IFNGR2, IGLL1, IKBKB, IKZF1, IKZF2, IL10, IL10RA, IL10RB, IL12B, IL12RB1, IL17F, IL17RA, IL17RC, IL1RN, IL21, IL21R, IL23R, IL2RA, IL2RB, IL2RG, IL36RN, IL6R, IL6ST, IL7R, IRF1, IRF2BP2, IRF7, IRF8, IRF9, ISG15, ITK, JAGN1, JAK1, JAK3, KRAS, LAMTOR2, LAT, LCK, LIG1, LIG4, LIPA, LPIN2, LRBA, LSM11, LYN, LYST, MAGT1, MALT1, MAP3K14, MCM10, MCM4, MCTS1, MEFV, MOGS, MS4A1, MSN, MTHFD1, MVK, NCF1, NCF2, NCF4, NCKAP1L, NFKB1, NFKB2, NHEJ1, NLRC4, NLRP1, NLRP12, NLRP3, NOD2, NRAS, OAS1, ORAI1, OTULIN, PGM3, PIK3CD, PIK3CG, PIK3R1, PLCG2, PNP, POLA1, POLR3A, POLR3F, POMP, PRF1, PRKCD, PRKDC, PSMA3, PSMB10, PSMB4, PSMB8, PSMB9, PSMG2, PSTPIP1, PTEN, PTPRC, RAB27A, RAC2, RAG1, RAG2, RASGRP1, REL, RELA, RELB, RFX5, RFXANK, RFXAP, RIPK1, RNASEH2A, RNASEH2B, RNASEH2C, RNU7-1, RORC, RPSA, SAMHD1, SASH3, SBDS, SEC61A1, SH2D1A, SH3KBP1, SKIC2, SKIC3, SLC29A3, SLC37A4, SLC39A7, SLC46A1, SLC7A7, SLCO2A1, SMARCD2, SP110, SPI1, SPINK5, SPPL2A, SRP54, STAT1, STAT2, STAT3, STAT5B, STAT6, STIM1, STING1, STK4, STX11, STXBP2, SYK, TAFAZZIN, TAP1, TAP2, TAPBP, TBX1, TBX21, TCF3, TET2, TFRC, TGFB1, TGFBR1, TGFBR2, TLR3, TLR7, TNFAIP3, TNFRSF13B, TNFRSF13C, TNFRSF1A, TNFRSF4, TNFRSF9, TOP2B, TRAF3IP2, TREX1, TRIM22, TRNT1, TTC7A, TYK2, UNC13D, UNC93B1, UNG, USB1, VPS13B, VPS45, WAS, WIPF1, XIAP, ZAP70, ZNF341, ZNFX1

Additional Services

HLA-Typing (HLA01)

HLA class I (Gene A, B, C) and HLA class II (Gene DPA1, DPB1, DQA1, DQB1, DRB1, DRB3, DRB4, DRB5)

ACMG Genes

Genetic variation may sometimes be identified, which does not fit within the scope of the requested genetic analysis (so-called secondary findings). The reporting of these variants is limited to pathogenic alterations (ACMG classes 4 and 5) within selected genes, for which a treatment or course of action exists for you or your family (according to the current guidelines of the American College of Medical Genetics and Genomics).

Details on genes and associated diseases can be found here

Pharmacogenetics

Pharmacogenetic analysis detects genetic changes that affect the effectiveness of drugs. Genetic variants that affect proteins responsible for the metabolism of substances can significantly change their tolerance and efficacy. These drugs include, among others, antidepressants, pain relievers, neuroleptics, chemotherapeutics, AIDS drugs, thrombosis drugs, anesthetics, beta-blockers, or statins.

The reduced activity of a specific enzyme can lead to an increased drug level in the standard dosage, which is often associated with undesirable side effects. With drugs that are only activated by metabolism, the therapeutic effect can be completely absent. Likewise, due to the resulting increased rate of degradation of the medicinal substance, an increased enzyme activity leads to inadequate effectiveness of the therapy.

The pharmacogenetics option analyzes known variants in twenty-two genes involved in the metabolism of drugs. If specific gene variants occur, the treating doctor can adapt the therapy individually. The pharmacogenetic analysis can minimize serious side effects and helps to avoid failure of the treatment.

Details on genes and more infomation can be found here

Downloads

Order Form PID
Sample Report PID

Contact Us

Do you have a question, or are you interested in our service?

The fields marked with (*) are mandatory and must be completed.

Diagnostic Support

We will assist you in selecting the diagnostic strategy – for each patient.

Keimbahn Team der CeGaT